Lv7
3540 积分 2024-08-14 加入
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
3个月前
已完结
Advancing therapeutics in small-cell lung cancer
3个月前
已完结
Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective
3个月前
已完结
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling
3个月前
已完结
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
3个月前
已完结
Covalent drug – An emerging framework for targeted drug development
3个月前
已完结
First-line lorlatinib versus crizotinib in Asian patients with advanced ALK-positive NSCLC: 5-year outcomes from the CROWN study
3个月前
已完结
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
4个月前
已完结
A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer
5个月前
已完结
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
7个月前
已完结
皖公网安备34019202002308
